









Markets
/
Stocks
/
nasdaq-ahco
/

Adapthealth Corp

AHCO

9.540USD

+0.140+1.49%

Close 11/11, 16:00（ET）Quotes delayed by 15 min

1.29BMarket Cap

17.30P/E TTM



Adapthealth Corp

9.540

+0.140+1.49%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Adapthealth Corp

Currency: USD Updated: 2025-11-11

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Adapthealth Corp's Score

Industry at a Glance

Industry Ranking

44 / 209

Overall Ranking

112 / 4608

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 8 analysts

Buy

Current Rating

13.250

Target Price

+40.96%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Adapthealth Corp Highlights

StrengthsRisks

Adapthealth Corp. provides patient-centered, healthcare-at-home solutions, including home medical equipment (HME), medical supplies and related services. The Company is primarily focused on providing sleep therapy equipment, supplies and related services, including CPAP and bi PAP services to individuals suffering from obstructive sleep apnea (OSA); medical devices and supplies to patients for the treatment of diabetes, including continuous glucose monitors (CGM) and insulin pumps; home medical equipment to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The Company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. It serves patients annually in all 50 states through its network of approximately 680 locations in 47 states.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 3.26B.

Turnaround to Profit

The company's performance has turned profitable, with the latest annual net income of USD .

Fairly Valued

The company’s latest PE is 17.03, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 141.08M shares, decreasing 8.46% quarter-over-quarter.

Held by HACAX

Star Investor HACAX holds 162.12K shares of this stock.

Financial Health

Currency: USD Updated: 2025-11-11

The company's current financial score is 8.81, which is higher than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 820.31M, representing a year-over-year increase of 1.79%, while its net profit experienced a year-over-year increase of 7.29%.

Score

Industry at a Glance

Previous score

8.81

Change



Financials

9.64

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

10.00

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

9.39

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

7.70

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.30

Key Metrics

Free cash flow

No Data

Adapthealth Corp's Company Valuation

Currency: USD Updated: 2025-11-11

The company’s current valuation score is 6.02, which is lower than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is 17.03, which is 194.49% below the recent high of 50.15 and 140.43% above the recent low of -6.89.

Score

Industry at a Glance

Previous score

6.02

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 44/209

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-11

The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for Adapthealth Corp is 13.00, with a high of 16.00 and a low of 10.50.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 8 analysts

Buy

Current Rating

13.250

Target Price

+40.96%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

110

Total

Median

Average

Company name

Ratings

Analysts

Adapthealth Corp

AHCO

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Dexcom Inc

DXCM

Zimmer Biomet Holdings Inc

ZBH

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-11

The company’s current price momentum score is 6.91, which is lower than the Healthcare Equipment & Supplies industry's average of 7.18. Sideways: Currently, the stock price is trading between the resistance level at 10.54 and the support level at 8.68, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.86

Change

0.05

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.017

Buy

RSI(14)

52.233

Neutral

STOCH(KDJ)(9,3,3)

39.077

Neutral

ATR(14)

0.471

High Vlolatility

CCI(14)

15.987

Neutral

Williams %R

61.126

Sell

TRIX(12,20)

0.268

Sell

StochRSI(14)

13.411

Oversold

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

9.678

Sell

MA10

9.526

Buy

MA20

9.437

Buy

MA50

9.211

Buy

MA100

9.259

Buy

MA200

9.294

Buy

Institutional Confidence

Currency: USD Updated: 2025-11-11

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.43. The latest institutional shareholding proportion is 104.17%, representing a quarter-over-quarter decrease of 6.36%. The largest institutional shareholder is The Vanguard, holding a total of 11.21M shares, representing 8.27% of shares outstanding, with 10.68% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

13.90M

-5.74%

One Equity Partners LLC

13.82M

The Vanguard Group, Inc.

Star Investors

11.79M

-3.24%

Deerfield Management Company, L.P.

9.90M

+1.99%

Fidelity Management & Research Company LLC

8.82M

+34.42%

Skyknight Capital, L.P.

8.58M

Everest Hill Group Inc.

7.59M

-12.17%

Reinhart Partners, LLC

7.31M

+1.06%

Dimensional Fund Advisors, L.P.

5.17M

+21.37%

Jefferies LLC

4.78M

+21.37%

Risk Assessment

Currency: USD Updated: 2025-11-11

The company’s current risk assessment score is 6.50, which is higher than the Healthcare Equipment & Supplies industry's average of 4.58. The company's beta value is 1.75. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.